[#item_full_content]AI has become the market’s biggest story, helping drive a surge in thematic investing and ETFs.…
Category: Finance
Financial Health, Fintech, Investment, Payments
Hot tech stock ETFs, from AI to quantum computing, have made investors lots of money. Is it time to sell?
[#item_full_content]AI has become the market’s biggest story, helping drive a surge in thematic investing and ETFs.…
JPMorgan Chase wins fight with fintech firms over fees to access customer data
[#item_full_content]The JPMorgan Chase deals mark a shift in the power dynamic between banks, middlemen and the…
Bitcoin falls below $95,000 as four-day rout picks up steam
[#item_full_content]The world’s oldest cryptocurrency fell below $95,000 on Friday, deepening its plunge into the red.
Investor Ron Baron says the tech selloff is an opportunity and he’s never selling personal Tesla stake
[#item_full_content]Baron said he’s already made about $8 billion from Tesla over the years and that he…
Bitcoin falls below $95,000 as four-day rout picks up steam
[#item_full_content]The world’s oldest cryptocurrency fell below $95,000 on Friday, deepening its plunge into the red.
CEO of Southeast Asia’s largest bank says AI adoption already paying off: ‘It’s not hope, it’s now’
[#item_full_content]DBS CEO Tan Su Shan says AI adoption efforts are already paying off, despite broader concerns…
CEO of Southeast Asia’s largest bank says AI adoption is already paying off: ‘It’s not hope, it’s now’
[#item_full_content]Amid fears of an AI bubble, much has been made of recent reports suggesting that AI…
Markets no longer view the December rate cut as a sure bet, with Fed officials casting doubts
[#item_full_content]Fed Chair Jerome Powell wasn’t kidding a couple weeks ago when he said a December rate…
TKO, Polymarket strike multiyear deal to integrate prediction markets into UFC events
[#item_full_content]The deal makes UFC and Zuffa Boxing the first sports organizations to incorporate prediction market technology…
Maybern Secures $50 Million in Series B Funding Led by Battery Ventures to Build a New Operating System for Private Capital
[#item_full_content]NEW YORK–(BUSINESS WIRE)–Maybern, the operating system for private funds, today announced it has raised $50 million…
TKO, Polymarket strike multiyear deal to integrate prediction markets into UFC events
[#item_full_content]The deal makes UFC and Zuffa Boxing the first sports organizations to incorporate prediction market technology…
Everest Advisors Achieves Key Growth Milestone, Expands Platform of Interim and Fractional Executives
[#item_full_content]NEWPORT BEACH, Calif.–(BUSINESS WIRE)– #BusinessTransformation–Everest Advisors grows its advisor network 40%, adding trusted C-suite leaders who…
TKO, Polymarket strike multiyear deal to integrate prediction markets into UFC events
[#item_full_content]The deal makes UFC and Zuffa Boxing the first sports organizations to incorporate prediction market technology…
LabGenius Therapeutics annonce une présentation par affiche au congrès ESMO 2025 sur l'immuno-oncologie
[#item_full_content]LONDRES–(BUSINESS WIRE)–LabGenius Therapeutics LabGenius (« LabGenius »), une société de découverte de médicaments associant l’intelligence artificielle…
Riassunto: LabGenius Therapeutics annuncia una presentazione poster all'ESMO Immuno-Oncology Congress 2025
[#item_full_content]LONDRA–(BUSINESS WIRE)–LabGenius Therapeutics (“LabGenius”), azienda di scoperta farmacologica che combina l’intelligenza artificiale (AI) con la sperimentazione…
Resumen: LabGenius Therapeutics anuncia la presentación de un póster en ESMO Immuno-Oncology Congress 2025
[#item_full_content]LONDRES–(BUSINESS WIRE)–LabGenius Therapeutics («LabGenius»), una empresa especializada en el desarrollo de fármacos que combina la inteligencia…
LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025
[#item_full_content]LONDON–(BUSINESS WIRE)– #AI–LabGenius Therapeutics (“LabGenius”), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation…
LabGenius Therapeutics kündigt Poster-Präsentation auf ESMO Immuno-Oncology Congress 2025 an
[#item_full_content]LONDON–(BUSINESS WIRE)–LabGenius Therapeutics („LabGenius“), ein auf die Wirkstoffentdeckung spezialisiertes Unternehmen, das künstliche Intelligenz (KI) und Hochdurchsatz-Experimente…
Samenvatting: LabGenius Therapeutics kondigt een posterpresentatie tijdens het ESMO Immuno-Oncology Congress 2025 aan
[#item_full_content]LONDEN–(BUSINESS WIRE)–LabGenius Therapeutics (“LabGenius”), een bedrijf dat zich toelegt op het ontdekken van geneesmiddelen en hiertoe…